TOKYO -- Shares in Fujifilm Holdings fell nearly 5% Wednesday morning, following reports that clinical trials have shown no clear evidence of its flu drug Avigan being effective in treating coronavirus patients.
Coronavirus
Fujifilm shares down 5% on negative Avigan report
Potential coronavirus treatment needs more data and further clinical trials
Shares in Fujifilm Holdings fell nearly 5% on Wednesday morning, following reports that the medicine does not show efficacy in fighting COVID-19. (photo by Takaki Kashiwabara)
Read Next
Latest on Coronavirus
